Product Information

GLYBURIDE 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0743 per EA under NDC 00093936401. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on May 1, 1984. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLYBURIDE 5 MG TABLET

glyburide
$0.0743per EA

Strength

5 mg/1

NDC

00093936401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GLYBURIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA017532

FDA Approved

5/1/1984

TE Code

AB2

On Market Since

5/1/1984

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLYBURIDE 5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 52.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0743 per EA
All-time high$0.1774 (Feb 12, 2014)
All-time low$0.0502 (May 22, 2024)
52-week high$0.0743
52-week low$0.0528
Median price$0.0974
Average price$0.1034
Largest weekly change+40.3% (Feb 22, 2023)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+8.9%

1M

+15.7%

3M

+16.4%

6M

+32.0%

1Y

+20.5%

3Y

+34.0%

5Y

-33.9%

All

-52.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLYBURIDE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0743 per EA (NDC 00093936401), effective Nov 18, 2026.

How has the price of GLYBURIDE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLYBURIDE 5 MG TABLET has declined 52.8%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLYBURIDE 5 MG TABLET?

Since Nov 28, 2013, the NADAC for GLYBURIDE 5 MG TABLET has ranged from a low of $0.0502 (May 22, 2024) to a high of $0.1774 (Feb 12, 2014), with a median of $0.0974 per EA.

Are there cheaper alternatives to GLYBURIDE 5 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE 5 MG TABLET, is $0.0655 per EA — about 12% below GLYBURIDE 5 MG TABLET.

Who manufactures GLYBURIDE 5 MG TABLET?

GLYBURIDE 5 MG TABLET (NDC 00093936401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.